NEW YORK (AP) — Pfizer is reporting fourth-quarter net income of .27 billion, which is better than anticipated.
The New York company’s per-share profit was .02, or 62 cents when adjusted for non-recurring gains and discontinued operations.
That’s 6 cents better than analysts polled by Zacks Investment Research had projected.
The drugmaker posted revenue of .7 billion in the period, also surpassing Wall Street expectations of .61 billion.
Pfizer expects full-year earnings in the range of .90 to per share, with revenue in the range of .5 billion to .5 billion.
Shares of Pfizer Inc. are up almost 2 percent in premarket trading Tuesday.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PFE at https://www.zacks.com/ap/PFE